Risks and benefits of bupropion treatment in schizophrenia: a systematic review of the current literature

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Englisch, Susanne (BerichterstatterIn) , Morgen, Katrin (BerichterstatterIn) , Meyer-Lindenberg, Andreas (BerichterstatterIn) , Zink, Mathias (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Clinical neuropharmacology
Year: 2013, Jahrgang: 36, Heft: 6, Pages: 203-215
ISSN:1537-162X
DOI:10.1097/WNF.0b013e3182a8ea04
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1097/WNF.0b013e3182a8ea04
Volltext
Verfasserangaben:Englisch, Susanne; Morgen, Katrin; Meyer-Lindenberg, Andreas; Zink, Mathias

MARC

LEADER 00000caa a22000002c 4500
001 1478404949
003 DE-627
005 20220811092328.0
007 cr uuu---uuuuu
008 140625s2013 xx |||||o 00| ||eng c
024 7 |a 10.1097/WNF.0b013e3182a8ea04  |2 doi 
035 |a (DE-627)1478404949 
035 |a (DE-576)408404949 
035 |a (DE-599)BSZ408404949 
035 |a (OCoLC)1340642575 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Risks and benefits of bupropion treatment in schizophrenia  |b a systematic review of the current literature  |c Englisch, Susanne; Morgen, Katrin; Meyer-Lindenberg, Andreas; Zink, Mathias 
264 1 |c 2013 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 25.06.2014 
700 1 |a Englisch, Susanne  |4 oth 
700 1 |a Morgen, Katrin  |0 (DE-588)1044344687  |0 (DE-627)771835787  |0 (DE-576)396904327  |4 oth 
700 1 |a Meyer-Lindenberg, Andreas  |d 1965-  |0 (DE-588)1029137390  |0 (DE-627)732483069  |0 (DE-576)376589876  |4 oth 
700 1 |a Zink, Mathias  |d 1968-  |0 (DE-588)121715221  |0 (DE-627)705627217  |0 (DE-576)292845715  |4 oth 
773 0 8 |i In  |t Clinical neuropharmacology  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1976  |g 36(2013), 6, Seite 203-215  |h Online-Ressource  |w (DE-627)330078143  |w (DE-600)2048796-4  |w (DE-576)09618888X  |x 1537-162X  |7 nnas  |a Risks and benefits of bupropion treatment in schizophrenia a systematic review of the current literature 
773 1 8 |g volume:36  |g year:2013  |g number:6  |g pages:203-215  |g extent:13  |a Risks and benefits of bupropion treatment in schizophrenia a systematic review of the current literature 
856 4 0 |u http://dx.doi.org/10.1097/WNF.0b013e3182a8ea04  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20140625 
993 |a Article 
994 |a 2013 
998 |g 121715221  |a Zink, Mathias  |m 121715221:Zink, Mathias  |d 60000  |e 60000PZ121715221  |k 0/60000/  |p 4  |y j 
998 |g 1029137390  |a Meyer-Lindenberg, Andreas  |m 1029137390:Meyer-Lindenberg, Andreas  |d 60000  |e 60000PM1029137390  |k 0/60000/  |p 3 
998 |g 1044344687  |a Morgen, Katrin  |m 1044344687:Morgen, Katrin  |d 60000  |e 60000PM1044344687  |k 0/60000/  |p 2 
999 |a KXP-PPN1478404949  |e 2803583089 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1097/WNF.0b013e3182a8ea04"],"eki":["1478404949"]},"relHost":[{"disp":"Risks and benefits of bupropion treatment in schizophrenia a systematic review of the current literatureClinical neuropharmacology","note":["Gesehen am 11.02.03"],"origin":[{"dateIssuedKey":"1976","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1976-","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Clinical neuropharmacology","title":"Clinical neuropharmacology"}],"part":{"issue":"6","year":"2013","pages":"203-215","text":"36(2013), 6, Seite 203-215","extent":"13","volume":"36"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1976 -"],"recId":"330078143","id":{"issn":["1537-162X"],"eki":["330078143"],"zdb":["2048796-4"]}}],"physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Englisch, Susanne; Morgen, Katrin; Meyer-Lindenberg, Andreas; Zink, Mathias"]},"recId":"1478404949","title":[{"title_sort":"Risks and benefits of bupropion treatment in schizophrenia","subtitle":"a systematic review of the current literature","title":"Risks and benefits of bupropion treatment in schizophrenia"}],"note":["Gesehen am: 25.06.2014"],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Susanne","role":"oth","family":"Englisch","display":"Englisch, Susanne"},{"display":"Morgen, Katrin","family":"Morgen","given":"Katrin","role":"oth"},{"family":"Meyer-Lindenberg","display":"Meyer-Lindenberg, Andreas","role":"oth","given":"Andreas"},{"display":"Zink, Mathias","family":"Zink","role":"oth","given":"Mathias"}]} 
SRT |a RISKSANDBE2013